Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001283303-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 16, 2026 |
| Document | View SEC Filing |
Transactions
11
Total Shares
140,500
Total Value
$2,792,401.68
P&L
+inf% (+$553,560.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer and GC | Common Stock | โ | Apr 13, 2026 | Grant/Award | 14,000 | $0.00 | $0.00 | 119,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 10,000 | $19.08 | $190,800.00 | 129,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 20,000 | $17.96 | $359,200.00 | 149,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Apr 14, 2026 | Exercise/Conversion | 7,500 | $15.46 | $115,950.00 | 156,711 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Apr 14, 2026 | Sale | 37,500 | $41.07 | $1,540,125.00 | 119,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Apr 14, 2026 | Sale | 7,215 | $41.93 | $302,516.29 | 111,996 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Apr 15, 2026 | Sale | 5,226 | $41.62 | $217,506.12 | 106,770 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Apr 15, 2026 | Sale | 1,559 | $42.53 | $66,304.27 | 105,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Employee stock option (right to buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 37,500 | Direct | โ | View Details | |
Chief Legal Officer and GC | Employee stock option (right to buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Legal Officer and GC | Employee stock option (right to buy) | Derivative | Apr 14, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details |